During the past decade, Hospital Universitario Infanta Leonor conducted 141 clinical trials. In the 10-year time frame, 141 clinical trials started and 35 clinical trials were completed, i.e. on average, 24.8% percent of trials that started reached the finish line to date. In the past 5 years, 81 clinical trials started and 25 clinical trials were completed. i.e. 30.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Infanta Leonor" #1 sponsor was "Fundacion SEIMC-GESIDA" with 16 trials, followed by "Janssen Research & Development, LLC" with 14 trials sponsored, "PETHEMA Foundation" with 10 trials sponsored, "Grupo Español de Rehabilitación Multimodal" with 8 trials sponsored and "Celgene" with 8 trials sponsored. Other sponsors include 111 different institutions and companies that sponsored additional 84 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Infanta Leonor" #1 collaborator was "Hospital Universitario Infanta Leonor" with 6 trials as a collaborator, "Eli Lilly and Company" with 5 trials as a collaborator, "Janssen, LP" with 4 trials as a collaborator, "Janssen-Cilag, S.A." with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 112 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Infanta Leonor" are "Multiple Myeloma" (12 trials), "COVID-19" (11 trials), "HIV Infections" (9 trials), "Covid19" (7 trials) and "Psoriasis" (7 trials). Many other conditions were trialed in "Hospital Universitario Infanta Leonor" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Infanta Leonor" are "Drug" (102 trials), "Other" (22 trials), "Biological" (13 trials), "Device" (12 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Dexamethasone" (9 trials), "Ibrutinib" (8 trials), "Rituximab" (8 trials) and "Bortezomib" (7 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Infanta Leonor" are 163 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 57 active trials in "Hospital Universitario Infanta Leonor". 4 are not yet recruiting, 34 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 82 completed trials in Hospital Universitario Infanta Leonor, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Infanta Leonor, 2 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 14 trials that are defined as “Not Applicable".

Hospital Universitario Infanta Leonor has several departments that took part in Clinical trials: "Hospital Infanta Sofia; Servico de Oncologia" - 3 trials, "Hospital Infanta Leonor; Servicio de Hematologia" - 3 trials, "Hospital Infanta Sofia; Servicio de Reumatologia" - 2 trials